Atopic dermatitis (eczema): open trials in China

7 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Beijing Children's Hospital, Capital Medical University, Beijing · Hunan Children's Hospital, Changsha · Hangzhou Third People's Hospital, Hangzhou · Dermatology Hospital of Jiangxi Province, Nanchang · Shanghai Children's Hospital, Shanghai · Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai · Shenzhen Children's Hospital, Shenzhen
Registry updated 2026-11-05
NCT07216027
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Trial Treatment · Phase 2 · Pfizer
Peking University People's Hospital, Beijing · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Guangdong Province Dermatology Hospital, Guangzhou · Huashan Hospital, Fudan University, Shanghai
Registry updated 2026-11-05
NCT06947993
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Beijing · Changchun · Changsha · Guangzhou · Hangzhou · Shanghai · Shantou
Registry updated 2026-09-28
NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Beijing Children's Hospital, Capital Medical University, Beijing · Hunan Children's Hospital, Changsha · Hangzhou Third People's Hospital, Hangzhou · Dermatology Hospital of Jiangxi Province, Nanchang · Shanghai Children's Hospital, Shanghai · Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai · Shenzhen Children's Hospital, Shenzhen
Registry updated 2026-09-25
NCT07573735
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Research · Zhongda Hospital
Zhongda Hospital Southeast University, Nanjing
Registry updated 2026-06-11
NCT06999941
A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
Research · Xi Tan
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-06-10
NCT05316805
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Research · Peking University First Hospital
Peking University First Hospital, Beijing
Registry updated 2024-08-15

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Atopic dermatitis (eczema): open trials in China

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project